Which women should take aspirin to prevent cardiovascular disease?

Article

It seems only those at high risk for stroke and at low risk for the adverse effects of aspirin (i.e., gastrointestinal bleeding and hemorrhagic stroke), according to the results of a recent cost-utility analysis.

It seems only those at high risk for stroke and at low risk for the adverse effects of aspirin (i.e., gastrointestinal bleeding and hemorrhagic stroke), according to the results of a recent cost-utility analysis.

Researchers determined that aspirin costs $13,300 per quality-adjusted life-year (QALY) gained in 65-year-old women with a moderate 10-year cardiovascular risk and that in these moderate-risk women, there is a 27% chance that aspirin will be less effective than no treatment.

Based on the results, preventive aspirin therapy is probably not appropriate for women at lower risk, including women 55 years and younger without additional stroke risk factors.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.